Podcaster Joe Rogan recently stopped drinking alcohol, he announced on a recent episode of “The Joe Rogan Experience." Neurosurgeon Dr. Brett Osborn shares the associated health risks.

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

Screens are steadily taking over more and more of our life, leading some researchers to worry about the effect of long-term ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

Users needing emergency care or hospitalization were more likely to later develop dementia, researchers reported. That does ...

In summary, GLP-1 receptor agonists, originally used to treat diabetes, are now being explored for brain protection. Two ...

A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...

including Ozempic and Wegovy, are “very important drugs” for type 2 diabetes, with increasing use for obesity. “Though these ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The study supports prior research that found the same thing.